Navigation Links
Cardium's InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Date:6/19/2008

on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.

Copyright 2008 Cardium Therapeutics, Inc. All rights reserved.

For Terms of Use Privacy Policy, please visit http://www.cardiumthx.com.

Cardium Therapeutics(TM) and Generx(TM) are trademarks of Cardium Therapeutics, Inc.

Tissue Repair(TM), Gene Activated Matrix(TM), GAM(TM) and Excellarate(TM) are trademarks of Tissue Repair Company.

InnerCool Therapies(R), InnerCool(R), Celsius Control System(TM), RapidBlue(TM), CoolBlue(TM) and Accutrol(TM) are trademarks of InnerCool Therapies, Inc.


'/>"/>
SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
2. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
3. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
4. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
5. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
6. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
7. Quest PharmaTech and BC Cancer Agency to Develop Immuno Photodynamic Therapies for Lung Cancer
8. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
9. Pipeline for Lung Cancer Therapies is Focus of New MedPredict Report
10. Teva Pharmaceuticals Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis
11. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...itzerland, Dec. 4 Octapharma,Chai...s D. Curtin has been,selected to lead Octapharma,...had been Octapharma,s U.S. legal counsel since 200...utics, Inc. , The largest private plasma pr...acquired Life Therapeutics, the Atlanta company th...
(Date:12/4/2008)...wswire-FirstCall/ -- NeoStem, Inc.,(NYSE Alternex...llection,processing and long-term storage of adu...unced that it has reached a major milestone in its...rst ever collection center for collection of,adul...cal need in New York,City and has chosen Bruce Ya...
(Date:12/4/2008)...Newswire/ -- Azur Pharma Limited ("Azur") today,a...eement with BioSante,Pharmaceuticals, Inc ("BioSa...Elestrin(TM). Elestrin is a fast drying gel formul...atment of moderate to severe vasomotor symptoms,a... the U.S. Food and Drug,Administration ("FDA") in...
(Date:12/4/2008)...PRNewswire/ -- Parion Sciences, Inc. today announc...ILD ), has initiated a Phase I,clinical trial of ...y and,tolerability of the investigational compoun...on for the treatment of pulmonary disease. Previo...um channel (ENaC) blocker discovered by,Parion, a...
Breaking Biology Technology:Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
... - A new 75,000-square-foot facility in the Dodge...room for an expanding healthcare technology compan...on 28 acres in the industrial park to replace two ...d. It moved into the new space in April. The new b...ated Peripherals Inc., more than twice the space a...
...lumn, I reviewed some of the key findings of a stu...nces of 25 of the largest practitioners of outsour...findings from another study conducted by the consu...roviders of IT outsourcing services. The complete ... third consecutive year that DiamondCluster has po...
...etavante Corp , the financial technology subsidiar...quisition, announced in June, of Herndon, Va.-base...nd consulting services to the financial industry. ...port management software in both lending and depos... Advanced Financial Solutions (AFS), a Metavante c...
...s. - The University of Wisconsin-Whitewater has r... line, developing what is now known as the Informa...gram, the successor the previously offered Compute...oint work between the school and the business sect... far greater emphasis than its predecessor on netw...
Other Biology Technology:Is outsourcing reaching its limits or simply pausing for breath? - Part II 2Is outsourcing reaching its limits or simply pausing for breath? - Part II 3Is outsourcing reaching its limits or simply pausing for breath? - Part II 4Whitewater upgrades tech degree program 2Whitewater upgrades tech degree program 3
(Date:12/3/2008)...e December 14-17, 2008 at the University,s Sede Bo...es of BGU,s Jacob Blaustein Institutes for Desert ...ference are the United Nations Educational, Scient...Ministry for Foreign Affairs, Jewish National Fund...lobal leader in smart water solutions for agricult...
(Date:12/3/2008)...arded as safe for pregnancy - other asthma drugs h...n usually keep using the same asthma drugs they we...ys are the best studied and can be regarded as saf...cessary however. According to the German Institute..., more data from trials could reassure women who w...
(Date:12/3/2008)... promises to enable cheap, lifesaving new drugs to...malaria, and to create innovative biofuels that ca... science and its applications are raising question...se scientists purposely changing the definition of...unintentionally equipping terrorists with frighten...
(Date:12/2/2008)...encing is easier than ever, but the amount of data...puter program now shows that genome sequence analy... researchers find hidden relationships in massive ...ent of Energy,s Pacific Northwest National Laborat... Supercomputing ,08 High Performance Computing Ana...
Breaking Biology News(10 mins):Ben-Gurion University of the Negev to host 2Pregnant women with asthma can be more confident about some medicines 2Synthetic biology: Is ethics a showstopper? 2PNNL researchers earn top honors at Supercomputing conference 2PNNL researchers earn top honors at Supercomputing conference 3Stanford Accelerates Union Busting Tactics 24694 1Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday August 6 2008 6838 1Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday August 6 2008 6838 2Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday August 6 2008 6838 3Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 1Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 2Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 3Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 4Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 5Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 6Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 7Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 8Neurocrine Biosciences Reports Second Quarter 2008 Results 6833 9Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 1Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 2Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 3Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 4Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 5Phase II Data on Lillys Antibody Show It Affects Amyloid Beta a Protein Believed To Be Associated with Alzheimers Disease 2756 6
...in exploring the potential future use of stem cell...ticle in the current issue of Nature (June 29, 200...scular Disease Director Deepak Srivastava, MD, and... Ivey, PhD, the paper cites a better understanding...mental processes within the heart that can be repr...
...overed that the human immunodeficiency virus, the ... to destroy it by hiding out in the mucosal tissue...nues to replicate in the gut mucosa, suppressing i...retroviral therapy--even when blood samples from t...rking. Results of the three-year study appear in t...
... Mesopotamian marshes since 2003 has resulted in a...vertebrates, plants, fish, and birds, according to...rtis J. Richardson of Duke University and Najah A....t fieldwork conducted over the past two years in f...r inflow from the Tigris and Euphrates rivers has ...
... agencies have concluded that the ozone hole over ...years later than previously believed. , Researcher...Administration (NOAA) and the National Center for ...ool, a math-based computer model, to predict the t...be published tomorrow in Geophysical Research Lett...
Other Biology News:Progress being made in exploring potential use of stem cells to treat heart disease 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 2UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery 3Iraq's marshes show progress toward recovery 2Scientists find Antarctic ozone hole to recover later than expected 2Scientists find Antarctic ozone hole to recover later than expected 3
...lvement of integrins in vascular proliferation, ad.... The integrin family of cell adhesion receptors c...imers, composed of an a and b subunit that associa...ctional diversity of the integrin family are based...
...ep ion exchange media are rigid macroporous hydrop...flow rates at moderate pressures, while the macrop... hydrophilic matrix reduces nonspecific binding. M... anion exchanger with very high flow rates and res...
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112
Biology Products: